NO20001219L - Blanding for medikament-administrasjon - Google Patents
Blanding for medikament-administrasjonInfo
- Publication number
- NO20001219L NO20001219L NO20001219A NO20001219A NO20001219L NO 20001219 L NO20001219 L NO 20001219L NO 20001219 A NO20001219 A NO 20001219A NO 20001219 A NO20001219 A NO 20001219A NO 20001219 L NO20001219 L NO 20001219L
- Authority
- NO
- Norway
- Prior art keywords
- mixture
- drug administration
- drug
- composition
- approximation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Farmasøytisk blanding omfattende polymeriske mikro- partikler, inkludert et medikament og en fettsyre, hvilken blanding kan tilpasses for å gi en fngivelses-hastighet som er tilnærmet lineær med tid, og uten å gi en betydelig sprengeffekt.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9718986.4A GB9718986D0 (en) | 1997-09-09 | 1997-09-09 | Controlled release microsphere delivery system |
PCT/GB1998/002692 WO1999012549A2 (en) | 1997-09-09 | 1998-09-07 | Controlled release microsphere delivery system |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20001219D0 NO20001219D0 (no) | 2000-03-09 |
NO20001219L true NO20001219L (no) | 2000-03-09 |
Family
ID=10818687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20001219A NO20001219L (no) | 1997-09-09 | 2000-03-09 | Blanding for medikament-administrasjon |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1011680A2 (no) |
JP (1) | JP2001515862A (no) |
AR (1) | AR017079A1 (no) |
AU (1) | AU745511B2 (no) |
CA (1) | CA2302762A1 (no) |
GB (1) | GB9718986D0 (no) |
NO (1) | NO20001219L (no) |
NZ (1) | NZ502710A (no) |
WO (1) | WO1999012549A2 (no) |
ZA (1) | ZA987762B (no) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194006B1 (en) | 1998-12-30 | 2001-02-27 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of microparticles having a selected release profile |
US6331317B1 (en) | 1999-11-12 | 2001-12-18 | Alkermes Controlled Therapeutics Ii Inc. | Apparatus and method for preparing microparticles |
US6495166B1 (en) | 1999-11-12 | 2002-12-17 | Alkermes Controlled Therapeutics Inc. | Apparatus and method for preparing microparticles using in-line solvent extraction |
US6705757B2 (en) | 1999-11-12 | 2004-03-16 | Alkermes Controlled Therapeutics, Inc. Ii | Method and apparatus for preparing microparticles using in-line solvent extraction |
ES2169980B1 (es) * | 1999-12-17 | 2003-11-01 | Lipotec Sa | Microcapsulas para la liberacion prolongada de farmacos. |
US6264987B1 (en) | 2000-05-19 | 2001-07-24 | Alkermes Controlled Therapeutics Inc. Ii | Method for preparing microparticles having a selected polymer molecular weight |
US6495164B1 (en) | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
US6824822B2 (en) | 2001-08-31 | 2004-11-30 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby |
US6471995B1 (en) | 2000-09-27 | 2002-10-29 | Alkermes Controlled Therapeutics, Inc. Ii | Apparatus and method for preparing microparticles using liquid-liquid extraction |
US20020114843A1 (en) | 2000-12-27 | 2002-08-22 | Ramstack J. Michael | Preparation of microparticles having improved flowability |
KR101139112B1 (ko) | 2002-06-25 | 2012-04-30 | 다케다 야쿠힌 고교 가부시키가이샤 | 서방성 조성물의 제조 방법 |
WO2004039411A2 (en) * | 2002-10-31 | 2004-05-13 | Pfizer Products Inc. | Solid and semi-solid polymeric ionic conjugates |
BRPI0415531B8 (pt) | 2003-10-23 | 2021-05-25 | Otsuka Pharma Co Ltd | formulação de aripiprazol injetável estéril de liberação controlada e método para a sua preparação |
ES2375802T3 (es) | 2004-04-15 | 2012-03-06 | Alkermes Pharma Ireland Limited | Dispositivo de liberación sostenida a base de pol�?mero. |
KR20070046892A (ko) | 2004-08-31 | 2007-05-03 | 화이자 프로덕츠 인크. | 저용해도 약물 및 중합체를 포함하는 제약 투여형 |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
DK2359808T3 (da) | 2006-08-09 | 2013-08-05 | Intarcia Therapeutics Inc | Osmotiske leveringssystemer og stempelaggregater |
CA2665101A1 (en) * | 2006-10-05 | 2008-04-10 | Panacea Biotec Ltd. | Injectable depot composition and it's process of preparation |
ES2791698T3 (es) | 2006-12-18 | 2020-11-05 | Takeda Pharmaceuticals Co | Composición de liberación sostenida y método para producir la misma |
EP2157967B1 (en) | 2007-04-23 | 2013-01-16 | Intarcia Therapeutics, Inc | Suspension formulations of insulinotropic peptides and uses thereof |
CA2695178C (en) | 2007-07-31 | 2015-06-23 | Otsuka Pharmaceutical Co., Ltd. | Methods for producing aripiprazole suspension and freeze-dried formulation |
WO2009102467A2 (en) | 2008-02-13 | 2009-08-20 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
LT2462246T (lt) | 2009-09-28 | 2017-11-27 | Intarcia Therapeutics, Inc | Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas |
CN103458895B (zh) * | 2010-11-25 | 2014-07-09 | 山东绿叶制药有限公司 | 罗替戈汀、其衍生物或罗替戈汀或其衍生物药用盐的组合物 |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
JO3410B1 (ar) | 2011-06-07 | 2019-10-20 | Otsuka Pharma Co Ltd | تركيبة أريبيبرازول مجفف بالتبريد |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
US10925639B2 (en) | 2015-06-03 | 2021-02-23 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
EP3733694A1 (en) | 2016-05-16 | 2020-11-04 | Intarcia Therapeutics, Inc | Glucagon-receptor selective polypeptides and methods of use thereof |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
CN110225762A (zh) | 2017-01-03 | 2019-09-10 | 因塔西亚制药公司 | 包括glp-1受体激动剂的连续施用和药物的共同施用的方法 |
JP2020511483A (ja) | 2017-03-20 | 2020-04-16 | テバ・ファーマシューティカルズ・インターナショナル・ゲーエムベーハーTeva Pharmaceuticals International GmbH | 徐放性オランザピン製剤 |
KR102045721B1 (ko) * | 2019-03-27 | 2019-11-18 | 주식회사 씨트리 | 아픽사반 함유 미립구 제조용 분산상의 조성물 및 이로부터 제조되는 생체적합성 고분자 기반 아픽사반 함유 미립구 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4384975A (en) * | 1980-06-13 | 1983-05-24 | Sandoz, Inc. | Process for preparation of microspheres |
US4389330A (en) * | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
GB9009229D0 (en) * | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
ATE188375T1 (de) * | 1992-11-17 | 2000-01-15 | Yoshitomi Pharmaceutical | Ein antipsychotikum enthaltende mikrokugel zur verzögerten freisetzung und verfahren für ihre herstellung |
EP0733368A1 (en) * | 1995-03-24 | 1996-09-25 | Eli Lilly And Company | Granule fomulation for olanzapine |
-
1997
- 1997-09-09 GB GBGB9718986.4A patent/GB9718986D0/en not_active Ceased
-
1998
- 1998-08-26 ZA ZA9807762A patent/ZA987762B/xx unknown
- 1998-09-07 AU AU89925/98A patent/AU745511B2/en not_active Ceased
- 1998-09-07 EP EP98941610A patent/EP1011680A2/en not_active Withdrawn
- 1998-09-07 CA CA002302762A patent/CA2302762A1/en not_active Abandoned
- 1998-09-07 NZ NZ502710A patent/NZ502710A/en unknown
- 1998-09-07 JP JP2000510446A patent/JP2001515862A/ja active Pending
- 1998-09-07 WO PCT/GB1998/002692 patent/WO1999012549A2/en not_active Application Discontinuation
- 1998-09-09 AR ARP980104487A patent/AR017079A1/es unknown
-
2000
- 2000-03-09 NO NO20001219A patent/NO20001219L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1011680A2 (en) | 2000-06-28 |
NZ502710A (en) | 2001-09-28 |
NO20001219D0 (no) | 2000-03-09 |
AU745511B2 (en) | 2002-03-21 |
AU8992598A (en) | 1999-03-29 |
WO1999012549A3 (en) | 1999-05-06 |
CA2302762A1 (en) | 1999-03-18 |
AR017079A1 (es) | 2001-08-22 |
GB9718986D0 (en) | 1997-11-12 |
ZA987762B (en) | 2000-02-28 |
WO1999012549A2 (en) | 1999-03-18 |
JP2001515862A (ja) | 2001-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20001219L (no) | Blanding for medikament-administrasjon | |
DK1032376T3 (da) | Anvendelse af benzhydrylsulfinylderivater til behandling af søvnighed af medicinal oprindelse | |
EE03137B1 (et) | Veterinaarravim ja protsess selle valmistamiseks | |
AU2901489A (en) | Onset-hastened/enhanced analgesia using s(+) ketoprofen | |
EP0130779A3 (en) | Pharmaceutical composition suitable for intestinal administration | |
MY111879A (en) | Pharmaceutical formulations. | |
DE69637961D1 (de) | Verabreichung von biologisch aktiven polypeptiden | |
IS1858B (is) | Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur | |
DK0954290T3 (da) | Farmaceutisk tablet med kontrolleret frigivelse indeholdende en bærer baseret på tværbundet amylose og hydroxypropylmethylcellulose | |
NO942325D0 (no) | Transdermalt administrert system som inneholder acetylsalicylsyre for tromboseterapi og cancerprofylakse | |
AU6346586A (en) | Therapeutic agents | |
HK1018590A1 (en) | Administration regimen of h+, k+-atpase inhibitors | |
DK0904067T3 (da) | Transdermalt indgivet dextromethorpan som hostestillende middel | |
NO955126L (no) | Mat-og/eller farmasöytisk blanding med lavt polyamininnhold og terapeutiske anvendelser derav | |
AU563831B2 (en) | N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives | |
KR910018020A (ko) | 프라바스타틴과 피브르산 유도체의 혼합제. 및 이 혼합제를 사용한 이상지혈증 치료 방법 | |
AU4519399A (en) | Anti-inflammatory pharmaceutical formulations | |
ATE137668T1 (de) | Vernetztes polyhydroxyl-material zur enzymatisch gesteuerten arzneistofffreisetzung | |
AU6889196A (en) | Long active composition for rectal administration | |
LV11728A (lv) | Farmaceitiska kompozicija | |
TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
DK0770082T3 (da) | Dioxo-thiopyrano-pyridin-carboxylsyrederivater og deres anvendelse som lægemidler | |
PL334093A1 (en) | Application of comt inhibitors in production of drugs preventing occurence of vascular disorders in case of diabetes | |
ATE46442T1 (de) | Arzneimittel zur behandlung chronisch entzuendlicher darmerkrankungen. | |
MX9701967A (es) | Uso de aparato de inyeccion accionado neumaticamente sin aguja. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |